@almoskow.bsky.social
Critical Care and Resuscitation. Montefiore CCM Division. Father of 3. Sleep deprived since 2015.
One of my favorite teachings from @xanderpharmd.bsky.social check out how different receptor binding is for each med—and we tend to use interchangeably!
November 28, 2024 at 9:17 PM
One of my favorite teachings from @xanderpharmd.bsky.social check out how different receptor binding is for each med—and we tend to use interchangeably!
November 17, 2024 at 5:46 PM
Nice Blue-sky-able chart. Interesting how any improve from CPC 2/3 to CPC 1
November 16, 2024 at 6:03 PM
Nice Blue-sky-able chart. Interesting how any improve from CPC 2/3 to CPC 1
Survival! If you survive the first month you’re likely to survive for years!! No difference between treatment groups
November 16, 2024 at 6:02 PM
Survival! If you survive the first month you’re likely to survive for years!! No difference between treatment groups
Tough to keep up with these patients
November 16, 2024 at 6:01 PM
Tough to keep up with these patients
What happens to these patients 5-8 YEARS later?
November 16, 2024 at 6:00 PM
What happens to these patients 5-8 YEARS later?
As a reminder these were the original results, better outcomes in 48 hour group but not significant
November 16, 2024 at 6:00 PM
As a reminder these were the original results, better outcomes in 48 hour group but not significant
Next up! Looking at long term outcomes after the TTM 24 vs 48hr trial. #emimcc #ReSS24 @pulmcrit.bsky.social @tscquizzato.bsky.social @nickjohnsonmd.bsky.social @joshkimbre.bsky.social
November 16, 2024 at 5:57 PM
Next up! Looking at long term outcomes after the TTM 24 vs 48hr trial. #emimcc #ReSS24 @pulmcrit.bsky.social @tscquizzato.bsky.social @nickjohnsonmd.bsky.social @joshkimbre.bsky.social
Better antibiotic resistance gene profile in the ceftriaxone group
November 16, 2024 at 5:16 PM
Better antibiotic resistance gene profile in the ceftriaxone group
Other improved outcomes in CTx group.
November 16, 2024 at 5:16 PM
Other improved outcomes in CTx group.
Less broad spectrum abx
November 16, 2024 at 5:15 PM
Less broad spectrum abx
Primary outcome of early-pneumonia less with CTx. NNT 3!
November 16, 2024 at 5:14 PM
Primary outcome of early-pneumonia less with CTx. NNT 3!
Outcome measures. Includes measures of antibiotic resistance! @xanderpharmd.bsky.social
November 16, 2024 at 5:12 PM
Outcome measures. Includes measures of antibiotic resistance! @xanderpharmd.bsky.social
The intervention! 2 grams of CTx q12 for 3 days
November 16, 2024 at 5:12 PM
The intervention! 2 grams of CTx q12 for 3 days
Late-breaking science session #ReSs24! First up the PROTECT trial examining ceftriaxone PPx after cardiac arrest @nickjohnsonmd.bsky.social @pulmtoilet.bsky.social @imcrit.bsky.social @pulmcrit.bsky.social
November 16, 2024 at 5:09 PM
Late-breaking science session #ReSs24! First up the PROTECT trial examining ceftriaxone PPx after cardiac arrest @nickjohnsonmd.bsky.social @pulmtoilet.bsky.social @imcrit.bsky.social @pulmcrit.bsky.social